
|Articles|November 1, 2004
D?j? vu all over again—again
Once more, the United States doesn't have enough of a vaccine—this time, flu vaccine. Just as the influenza season was about to start, the bad news hit the headlines: The entire output of the California-based Chiron company's influenza vaccine has been condemned by the authorities in the United Kingdom, where Chiron's vaccine, Fluvinir, is manufactured. US authorities had counted on 100 million doses of flu vaccine this year—up from 87 million available last year. About half that amount was to be supplied by Chiron.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP updates guidance on pediatric iron deficiency screening and treatment
2
Pediatric clinical trial update: Q2 2026
3
FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis
4
Sequential bilateral TMS linked to improvement in youth treatment-resistant depression
5





